Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02582749
Title Androgen Deprivation Therapy +/- Radium-223 Dichloride in Metastatic Prostate Cancer With Bone Metastases
Recruitment Terminated
Gender male
Phase Phase II
Variant Requirements No
Sponsors Ajjai Alva, MD
Indications

prostate adenocarcinoma

Therapies

Bicalutamide + Radium Ra 223 dichloride

Bicalutamide

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.